0001831293-25-000002.txt : 20250923 0001831293-25-000002.hdr.sgml : 20250923 20250923164937 ACCESSION NUMBER: 0001831293-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250923 DATE AS OF CHANGE: 20250923 EFFECTIVENESS DATE: 20250923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hera Biotech, Inc. CENTRAL INDEX KEY: 0001831293 ORGANIZATION NAME: EIN: 844843182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-558408 FILM NUMBER: 251334308 BUSINESS ADDRESS: STREET 1: 4725 COLLEGE PARK, SUITE 200 CITY: SAN ANTONIO STATE: TX ZIP: 78249 BUSINESS PHONE: 2106831069 MAIL ADDRESS: STREET 1: 4725 COLLEGE PARK, SUITE 200 CITY: SAN ANTONIO STATE: TX ZIP: 78249 D 1 primary_doc.xml X0708 D LIVE 0001831293 Hera Biotech, Inc. 4725 COLLEGE PARK, SUITE 200 SAN ANTONIO TX TEXAS 78249 2106831069 DELAWARE None None Corporation true Somer Baburek 4725 College Park Suite 200 San Antonio TX TEXAS 78249 Executive Officer Director Paul Castella 4725 College Park Suite 200 San Antonio TX TEXAS 78249 Director Wendy Smith 4725 College Park Suite 200 San Antonio TX TEXAS 78249 Director Neal Walsdorf, Jr. 4725 College Park Suite 200 San Antonio TX TEXAS 78249 Director Biotechnology Decline to Disclose 06b false 2025-04-11 true true true false 0 5000000 796328 4203672 false 8 0 0 0 A portion of the proceeds will be used to pay compensation to the execution officers named in response to Item 3 above. false Hera Biotech, Inc. Somer Barburek Somer Barburek CEO 2025-09-23